PCMH
BNTX icon

Polymer Capital Management (HK)’s BioNTech BNTX Stock Holding History

Polymer Capital Management (HK)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$2.38M – 179
2024
Q3 		$2.38M Hold
20,000
– – 0.55% 55
2024
Q2 		$1.61M Hold
20,000
– – 0.33% 69
2024
Q1 		$1.84M Buy
+20,000
New +$1.92M 0.46% 59

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Polymer Capital Management (HK)'s BNTX Position: Q4 2024 in Review

Polymer Capital Management (HK) sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 20,000 shares — an estimated $2.38M sold.

Polymer Capital Management (HK) first reported a position in BNTX in Q1 2024 and held it in 3 quarters. The position peaked at $2.38M in Q3 2024. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Polymer Capital Management (HK) reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Polymer Capital Management (HK) sold 20,000 BioNTech shares in Q4 2024, an estimated $2.38M.
  • Polymer Capital Management (HK) first reported a position in BioNTech in Q1 2024 and held it in 3 quarters.
  • Polymer Capital Management (HK)'s BioNTech position peaked at $2.38M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Polymer Capital Management (HK)'s 13F filing for Q4 2024, filed 13 Feb 2025.